Cargando…
Post-Injury Treatment with 7,8-Dihydroxyflavone, a TrkB Receptor Agonist, Protects against Experimental Traumatic Brain Injury via PI3K/Akt Signaling
Tropomyosin-related kinase B (TrkB) signaling is critical for promoting neuronal survival following brain damage. The present study investigated the effects and underlying mechanisms of TrkB activation by the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) on traumatic brain injury (TBI). Mice subjected...
Autores principales: | Wu, Chun-Hu, Hung, Tai-Ho, Chen, Chien-Cheng, Ke, Chia-Hua, Lee, Chun-Yen, Wang, Pei-Yi, Chen, Szu-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240709/ https://www.ncbi.nlm.nih.gov/pubmed/25415296 http://dx.doi.org/10.1371/journal.pone.0113397 |
Ejemplares similares
-
The TrkB agonist, 7,8-dihydroxyflavone, impairs fracture healing in mice
por: Johnstone, Maddison R., et al.
Publicado: (2021) -
Activation of TrkB/Akt signaling by a TrkB receptor agonist improves long-term histological and functional outcomes in experimental intracerebral hemorrhage
por: Wu, Chun-Hu, et al.
Publicado: (2019) -
7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders
por: Liu, Chaoyang, et al.
Publicado: (2016) -
7,8-Dihydroxyflavone protects neurons against oxygen-glucose deprivation induced apoptosis and activates the TrkB/Akt pathway
por: Zhou, Qinxiang, et al.
Publicado: (2022) -
Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins
por: Chitranshi, Nitin, et al.
Publicado: (2015)